Basel Medical shares surge 10.83% intraday after appointing Darren Tan to board following Jianing Lu’s resignation.

Basel Medical surged 10.83% intraday following the announcement that Darren Tan, the company’s Chief Commercial Officer, has been appointed to the board of directors, replacing Jianing Lu, who resigned from the board but will remain as CFO. The appointment, disclosed via a regulatory filing with the SEC, was viewed as a strategic leadership move that could signal stronger commercial direction and corporate governance, potentially boosting investor confidence. While no specific rationale for the change was provided, the timing and nature of the board reshaping likely contributed to the sharp intraday increase in share price.